Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
Do computerized mole-mapping tools play a role in your clinical practice?
Are they effective adjuncts in diagnosing atypical pigmented lesions?
Related Questions
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
What is your preferred treatment for actinic cheilitis?
Have you considered intralesional cempilumab for locally advanced NMSC/KCs prior to surgery?
How effective is the use of genomic testing methods, such as tape strip tests, for assessing suspicious pigmented lesions in clinical practice?
In what clinical scenarios do you consider pre- or post-treatment with Imiquimod for cutaneous melanoma?
How would you manage a large area of multiple, recurrent cutaneous squamous cell carcinomas of the scalp with ulcerations and non-healing areas despite cryotherapy, multiple Mohs procedures, and 5-FU?
How frequently do you recommend skin cancer screens in your patients with kidney transplants who are on immunosuppression?
What is the recommended approach for systemic therapy in a patient with metastatic cutaneous squamous cell carcinoma with active autoimmune disease (dermatomyositis)?
When do you recommend SRT, if ever, for small SCCs and BCCs?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?